325 results
Page 9 of 17
8-K
7ei an0xhmhbd642
16 Feb 12
Regulation FD Disclosure
12:00am
8-K
EX-99
2jkw8ot0wgeu2wb6zui2
9 Feb 12
Results of Operations and Financial Condition
12:00am
8-K
EX-99
ltyezx zs3k4aak3y0vy
9 Jan 12
Other Events
12:00am
8-K
EX-10.1
6wlj bs0dj
6 Jan 12
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-99.1
wss7zyofkih2p5b
2 Dec 11
Other Events
12:00am
8-K/A
EX-99.2
8g85ed0fsnhlqee9q
2 Dec 11
Other Events
12:00am
8-K
EX-99.1
j5q5 towm8e
27 Oct 11
Other Events
12:00am
8-K
EX-99
i4969l71n1t
27 Oct 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99.2
jpwnqk
26 Sep 11
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation in COPD
12:00am
8-K
dxivz 1rfutkvu
26 Sep 11
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation in COPD
12:00am
8-K
EX-99.3
yhmu8cin
26 Sep 11
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation in COPD
12:00am
8-K
EX-99.4
ro7bgtpffy5058u0
26 Sep 11
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation in COPD
12:00am
8-K
EX-99.1
v9o0ipol2ljo n0
26 Sep 11
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation in COPD
12:00am
8-K
EX-99
v92zvx iavmvo
15 Sep 11
Other Events
12:00am
8-K
EX-99
j6p5duhk2myv38q5z5
28 Jul 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99
0osx7skg ntnpsjb6zo
20 May 11
Other Events
12:00am
8-K
EX-99.1
tbpusrui xu3x9
17 May 11
Dose-related efficacy and optimal once-daily dosing interval of the long-acting beta2
12:00am